These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 30361120)

  • 1. Perforation of a Saphenous Vein Graft Anastomosed at a Y-Configuration to the Left Internal Mammary Artery.
    Triantafyllis AS; Haeck JDE; van Dijk EGJA; Brueren GRG; Spartalis E; Tonino PAL
    Cardiovasc Revasc Med; 2019 Aug; 20(8):716-719. PubMed ID: 30361120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distal embolic protection device transit through a left internal mammary artery for safely treating a saphenous vein graft anastomosed with a Y-configuration.
    Corda G; Talanas G; Murgia A; Parodi G
    J Cardiovasc Med (Hagerstown); 2020 Apr; 21(4):333-334. PubMed ID: 31789716
    [No Abstract]   [Full Text] [Related]  

  • 3. Successful deployment of polytetrafluoroethylene-covered stent to seal left internal mammary artery graft perforation due to guide catheter extension system.
    Ichimoto E; De Gregorio J
    Cardiovasc Revasc Med; 2016 Dec; 17(8):574-577. PubMed ID: 27394179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percutaneous saphenectomy: a potentially dreadful complication of cutting balloon angioplasty in saphenous vein grafts.
    Tassanawiwat W; Biondi-Zoccai GG; Sangiorgi G; Iakovou I; Tsagalou E; Melzi G; Ge L; Morici N; Corvaja N; Colombo A
    Int J Cardiol; 2006 Jan; 106(3):418-9. PubMed ID: 16337059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late Spontaneous Rupture of a Saphenous Vein Graft.
    Koshy GB; Hale A; Srouji D; Kim S; Wildes D
    Methodist Debakey Cardiovasc J; 2020; 16(4):318-322. PubMed ID: 33500762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency and predictors of drug-eluting stent use in saphenous vein bypass graft percutaneous coronary interventions: a report from the American College of Cardiology National Cardiovascular Data CathPCI registry.
    Brilakis ES; Wang TY; Rao SV; Banerjee S; Goldman S; Shunk K; Kar B; Holmes DR; Dai D; Chin CT; Harding TM; Roe MT
    JACC Cardiovasc Interv; 2010 Oct; 3(10):1068-73. PubMed ID: 20965466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Covered stent to treat saphenous venous graft perforation--a case report.
    Baruah DK
    Catheter Cardiovasc Interv; 2010 Nov; 76(6):844-6. PubMed ID: 20814899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous saphenous vein graft intervention with sequential embolic protection devices: complementing lesion anatomy with embolic protection device.
    Grow P; Rab ST
    Catheter Cardiovasc Interv; 2008 Nov; 72(5):636-40. PubMed ID: 18942125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distal coronary perforation in patients with prior coronary artery bypass graft surgery: The importance of early treatment.
    Karatasakis A; Akhtar YN; Brilakis ES
    Cardiovasc Revasc Med; 2016 Sep; 17(6):412-7. PubMed ID: 27465517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiarterial grafts improve the rate of early major adverse cardiac and cerebrovascular events in patients undergoing coronary revascularization: analysis of 12 615 patients with multivessel disease.
    Locker C; Schaff HV; Daly RC; Bell MR; Frye RL; Stulak JM; Said SM; Dearani JA; Joyce LD; Greason KL; Pochettino A; Li Z; Lennon RJ; Lerman A
    Eur J Cardiothorac Surg; 2017 Oct; 52(4):746-752. PubMed ID: 28595326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Closure of guide wire-induced coronary artery perforation with a two-component fibrin glue.
    Störger H; Ruef J
    Catheter Cardiovasc Interv; 2007 Aug; 70(2):237-40. PubMed ID: 17420994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical presentation and angiographic characteristics of saphenous vein graft failure after stenting: insights from the SOS (stenting of saphenous vein grafts) trial.
    Lichtenwalter C; de Lemos JA; Roesle M; Obel O; Holper EM; Haagen D; Saeed B; Iturbe JM; Shunk K; Bissett JK; Sachdeva R; Voudris VV; Karyofillis P; Kar B; Rossen J; Fasseas P; Berger P; Banerjee S; Brilakis ES
    JACC Cardiovasc Interv; 2009 Sep; 2(9):855-60. PubMed ID: 19778774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From debulking to delivery: sequential use of rotational atherectomy and Guidezilla™ for complex saphenous vein grafts intervention.
    Pellicano M; Floré V; Barbato E; De Bruyne B
    BMC Cardiovasc Disord; 2018 Jun; 18(1):122. PubMed ID: 29921223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of the Proxis embolic protection device for guide anchoring and stent delivery during complex saphenous vein graft interventions.
    Banerjee S; Brilakis ES
    Cardiovasc Revasc Med; 2009; 10(3):183-7. PubMed ID: 19595401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes after implantation of the TAXUS paclitaxel-eluting stent in saphenous vein graft lesions: results from the ARRIVE (TAXUS Peri-Approval Registry: A Multicenter Safety Surveillance) program.
    Brilakis ES; Lasala JM; Cox DA; Berger PB; Bowman TS; Starzyk RM; Dawkins KD
    JACC Cardiovasc Interv; 2010 Jul; 3(7):742-50. PubMed ID: 20650436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of chronic renal insufficiency on clinical outcomes in patients undergoing saphenous vein graft intervention with drug-eluting stents: a multicenter Southern Californian Registry.
    Lee MS; Hu PP; Aragon J; Shah A; Bhatia R; Jones N; Penny W; French W; Tobis J; Mahmud E
    Catheter Cardiovasc Interv; 2010 Aug; 76(2):272-8. PubMed ID: 20623716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continued benefit from paclitaxel-eluting compared with bare-metal stent implantation in saphenous vein graft lesions during long-term follow-up of the SOS (Stenting of Saphenous Vein Grafts) trial.
    Brilakis ES; Lichtenwalter C; Abdel-karim AR; de Lemos JA; Obel O; Addo T; Roesle M; Haagen D; Rangan BV; Saeed B; Bissett JK; Sachdeva R; Voudris VV; Karyofillis P; Kar B; Rossen J; Fasseas P; Berger P; Banerjee S
    JACC Cardiovasc Interv; 2011 Feb; 4(2):176-82. PubMed ID: 21349456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug eluting versus bare metal stents for percutaneous coronary intervention of saphenous vein graft lesions: An updated meta-analysis of randomized controlled trials.
    Ha FJ; Nogic J; Montone RA; Cameron JD; Nerlekar N; Brown AJ
    Cardiovasc Revasc Med; 2018; 19(7 Pt B):837-844. PubMed ID: 29685385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of long-term outcomes of drug-eluting stents and bare metal stents for saphenous vein graft stenosis.
    Chakravarty T; Morrissey RP; Wertman B; Naghi J; Chou S; Goykhman P; Doctor N; Mirocha J; Forrester JS; Makkar R
    Catheter Cardiovasc Interv; 2012 May; 79(6):903-9. PubMed ID: 21805570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Follow-up results after interventional treatment of infarct-related saphenous vein graft occlusion.
    Hoffmann R; Nitendo G; Deserno V; Adamu U; Almalla M; Blindt R; Vogt F
    Coron Artery Dis; 2010 Mar; 21(2):61-4. PubMed ID: 20124993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.